First CAR T-cell Tx for Mantle Cell Lymphoma Fills Unmet Need First CAR T-cell Tx for Mantle Cell Lymphoma Fills Unmet Need

Lymphoma specialist Ann LaCasce, MD, comments on brexucabtagene autoleucel, the first FDA-approved CAR T-cell therapy for relapsed or refractory mantle cell lymphoma.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news